XML 58 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Activity in Stock Award Plans
The activity in the Director Plan is displayed in the following table:
Authorized Shares Available for Future Award Grants
Year Ended December 31, 2017
 
From Inception to December 31, 2017
Beginning balance
74,771

 
300,000

Number of awards granted
(12,958
)
 
(262,190
)
Number of awards forfeited or expired

 
24,003

Ending balance
61,813

 
61,813

Number of option awards exercised
36,808

 
89,281

Number of restricted stock awards vested
22,716

 
54,272

The activity in the Stock Plan is displayed in the following table:
Authorized Shares Available for Future Award Grants
Year Ended December 31, 2017
 
From Inception to December 31, 2017
Beginning balance
1,248,651

 
1,900,000

Additional shares authorized

 
1,500,000

Number of awards granted
(259,405
)
 
(2,871,971
)
Number of awards forfeited or expired
7,582

 
468,799

Ending balance
996,828

 
996,828

Number of option awards exercised
136,827

 
1,085,895

Number of unrestricted stock awards granted
1,145

 
8,470

Number of restricted stock awards vested
1,198

 
38,168

Recognition of Stock-Based Compensation Expense
We expect this compensation to be recognized in subsequent years according to the following table, except with respect to awards that are accelerated by the Board of Directors, in which case we will recognize any remaining compensation expense in the period in which the awards are accelerated.
2018
 
$
4,028

2019
 
2,776

2020
 
1,116

2021
 
390

2022
 
40

Total
 
$
8,350

Analysis of Award Activity
The analysis below details the award activity for 2017 and the awards outstanding at December 31, 2017, for both of our plans and ad hoc options, which were granted prior to the adoption of the other plans:
Options
Shares
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Life (in years)
 
Aggregate Intrinsic Value
Outstanding at January 1, 2017
1,120,677

 
$
29.08

 
 
 
 
Granted
159,709

 
41.75

 
 
 
 
Exercised
(173,635
)
 
27.52

 
 
 
 
Forfeited or expired
(5,700
)
 
28.66

 
 
 
 
Outstanding at December 31, 2017
1,101,051

 
$
31.16

 
6.52
 
$
15,875

Exercisable at December 31, 2017
495,089

 
$
26.77

 
3.22
 
$
9,311

Schedule of Restricted Stock Award Activity
The analysis below details the award activity for the restricted stock and restricted stock unit awards outstanding at December 31, 2017:
Restricted stock awards
Shares
 
Weighted-Average Grant Date Fair Value
Non-vested at January 1, 2017
182,086

 
$
34.08

Granted
111,509

 
41.94

Vested
(23,914
)
 
36.77

Forfeited
(1,882
)
 
40.27

Non-vested at December 31, 2017
267,799

 
$
37.07

Weighted-average Grant-Date Fair Value Assumptions
The weighted-average grant-date fair value of the options granted under our plans has been estimated using the Black-Scholes option pricing model with the following weighted-average assumptions:
December 31,
2017
 
2016
 
2015
Risk-free interest rate
2.23
%
 
1.53
%
 
1.94
%
Expected volatility
27.58
%
 
25.44
%
 
21.92
%
Expected option life (in years)
7

 
7

 
7

Expected dividends (in dollars)
$
1.00

 
$
0.88

 
$
0.80

Weighted-average grant-date fair value of options granted during the year (in dollars)
$
9.93

 
$
8.42

 
$
4.98

Summary of Stock Options Outstanding and Exercisable
The following table summarizes information regarding the stock options outstanding and exercisable at December 31, 2017:
 
 
 
Options Outstanding
Options Exercisable
Range of Exercise Prices
Number Outstanding (in shares)
Weighted-Average Remaining Contractual Life (in years)
Weighted-Average Exercise Price
Number Exercisable (in shares)
Weighted-Average Exercise Price
$
15.01

-
21.00
100,805

3.23
$
20.24

100,805

$
20.24

21.01

-
28.00
159,478

4.52
23.38

127,077

23.23

28.01

-
35.00
508,630

6.42
29.49

235,833

29.74

35.01

-
43.00
332,138

8.63
40.77

31,374

39.84

$
15.01

-
43.00
1,101,051

6.52
$
31.16

495,089

$
26.77